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A fundamental principle in biology is that the program for early development is 
established during oogenesis in the form of the maternal transcriptome1,2. How the 
maternal transcriptome acquires the appropriate content and dosage of transcripts is 
not fully understood. Here we show that TUT4/7-mediated mRNA 3ʹ terminal 
uridylation sculpts the mouse maternal transcriptome by eliminating transcripts during 
oocyte growth. TUT4/7-mediated uridylation is essential for both oocyte maturation and 
fertility. In comparison to somatic cells, the oocyte transcriptome displays shorter 
poly(A) tail length and a high relative proportion of terminal oligo-uridylation. TUT4/7 
deletion leads to the accumulation of a cohort of transcripts with a high frequency of 
very short poly(A) tails and a loss of 3ʹ oligo-uridylation. In contrast, TUT4/7-deficiency 
does not alter gene expression in a variety of somatic cells. In summary, we show 
essential and specific functions for poly(A) tail length and 3ʹ terminal uridylation in 
sculpting a functional maternal transcriptome. 
 
The early stages of zygotic development are characterized by the lack of transcription and 
thus gene expression is instructed by the maternally-deposited transcriptome1. In mammals, 
the maternal transcriptome is built during folliculogenesis that encompasses the growth phase 
of oogenesis and culminates in ovulation2. This process initiates when a clutch of primordial 
oocytes begins to grow coinciding with the expansion of surrounding somatic cells that 
together will form follicles. The stages of growing oocytes are classified sequentially as 
primary, secondary, early antral or late antral depending on morphology and increasing cell 
size (Fig. 1a). The mature oocyte upon ovulation is competent to support fertilization as well 
as development3; this competence is largely defined by the maternal transcriptome4,5. The 
maternal mRNA in growing oocytes is extremely stable6,7, however, each stage of growth is 
characterized by a distinct transcriptome4. This implies that growing oocytes not only require 
the ability to accumulate mRNA but also to mediate its selective and limited degradation. 
How the growing oocyte eliminates transcripts to accrue the appropriate content and dosage 
of mRNAs defining a functional maternal transcriptome remains largely unknown.  
 
Poly(A) tail length and 3ʹ terminal mRNA uridylation are key determinants of mRNA 
turnover8–10. In human cell lines approximately a fifth of transcripts with very short poly(A) 
tails (< 25 nucleotides) is 3ʹ uridylated and this nucleotide addition optimizes the mRNA for 
decay9,11. The shortening of a poly(A) tail below ~27 nucleotides results in the loss of the 
stabilizing PABP binding12,13 and the subsequent recruitment of the terminal uridylyl 
transferases 4 (TUT4) and TUT7 (TUT4/7) that mediate mRNA 3ʹ uridylation9. LSM (like-
Sm) proteins are central regulators of RNA metabolism and have a binding preference for 
terminal uridylyl residues14, thus their recruitment sets in motion the 5ʹ-3ʹ XRN1 decay 
pathway through the recruitment of DCP1/2 mRNA decapping enzymes15. The contribution 
of TUT4/7-mediated 3ʹ uridylation to mRNA degradation in vivo and physiology is 
undetermined. Here we sought to understand if poly(A) tail length and mRNA 3ʹ uridylation 
function in the formation of the maternal transcriptome.  
 
To explore a possible contribution of TUT4/7-mediated mRNA uridylation during oocyte 
growth, we generated epitope-tagged alleles for both genes (Extended Data Fig. 1a-f). Both 
TUT4 and TUT7 proteins were expressed from the primordial through to late antral stages of 
oogenesis (Extended Data Fig. 1g). We next sought to understand the terminal uridylation 
profile and poly(A) tail features (3ʹ-terminome) of the GV (late antral/preovulatory) oocyte 
transcriptome. We therefore performed TAIL-seq11 with a slight modification to correct for 
poly(A) tail length recovery bias (Methods and Extended Data Fig. 2a, b) from GV oocytes 
as well as from somatic mouse tissues/cells (liver, bone marrow, mouse embryonic 
fibroblasts (MEFs) and embryonic stem cells (ESCs)). TAIL-seq enables the simultaneous 
determination of poly(A) tail length and the 3ʹ terminal nucleotides11. Oocytes had the 
poly(A) tail length distribution with the shortest mode length (~65 nucleotides) over the 78 
nucleotides observed (Fig. 1b). While the overall amount of terminal uridylation in the 
respective transcriptomes differed (Fig. 1c), a distinguishing feature of the GV oocyte was 
that it presented the highest relative ratio of oligo- to mono-uridylation among the respective 
transcriptomes (Fig. 1d, e and Extended Data Fig. 2c). 
 
Intrigued by the distinguishing features of the GV oocyte terminome, we sought to use 
conditional mutagenesis to explore the function of TUT4/7-mediated uridylation during 
oogenesis. We therefore engineered conditional alleles for both genes in the mouse (Extended 
Data Fig. 3a-e) and combined these Tut4Fl and Tut7Fl alleles with a Zp3Cre transgene that 
deletes at the secondary oocyte stage16 to generate control Tut4+/Fl; Tut7+/Fl; Zp3Cre Tg+ or 
Tut4+/+; Tut7+/+; Zp3Cre Tg+ (Tut4/7CTL) and experimental Tut4Fl/Fl; Tut7Fl/Fl; Zp3Cre Tg+ 
(Tut4/7cKO) mice. Tut4/7cKO mice were infertile, although they ovulated normal numbers of 
oocytes (Fig. 2a-c). The morphology of antral follicles in the Tut4/7cKO mice was also normal 
with a slight decrease in the frequency of surrounded nucleolus state oocytes observed 
(Extended Data Fig. 4a, b). To understand why the mutant oocytes were defective, we 
hormone primed and set up Tut4/7CTL and Tut4/7cKO females with wild type males and placed 
isolated oocytes/zygotes in culture to monitor pre-implantation development in vitro. Over 
the course of five days, the bulk of Tut4/7CTL embryos developed until the blastocyst stage; 
although sperm contact was observed with Tut4/7cKO oocytes, the majority of them did not 
develop further (Fig. 2d). A small fraction of the Tut4/7cKO fertilized oocytes were observed 
at the 2-pronuclei stage but never developed past 2-cell embryos (Fig. 2d). In summary, 
Tut4/7cKO oocytes are incompetent to support early embryonic development. This phenotype 
could arise from failure to complete meiosis I properly thus generating aberrant MII oocytes, 
or alternatively, Tut4/7cKO oocytes complete meiosis I correctly but the resulting MII oocytes 
are not capable of supporting fertilization. To discriminate between these two possibilities, 
Tut4/7CTL and Tut4/7cKO females were hormone primed and ovulated oocytes were isolated. 
The majority of Tut4/7cKO oocytes failed to complete meiosis I properly and multiple 
phenotypic abnormalities were observed, including abnormal spindle morphology with 
microtubule asters (Fig. 2e-II), telophase arrest (Fig. 2e-III) as well as aberrant MII oocytes 
with chromosomes dispersed along the spindle (Fig. 2e-IV). This defective meiosis could 
also be observed with in vitro cultured GV oocytes with most oocytes failing to extrude the 
first polar body (Extended Data Fig. 4c, d). We next wanted to formally determine if the 
uridylation activity of TUT4/7 is the principal function by which these large multidomain 
enzymes support meiosis I. We therefore took advantage of a previously characterized 
mutation in the catalytic triad (DDD to AAD) that renders TUT4 enzymatically inactive17,18 
and engineered a Tut4AAD allele in the mouse (Extended Data Fig. 3f-i). We then combined 
the Tut4Fl, Tut7Fl, Tut4AAD and Zp3Cre alleles to generate experimental Tut4Fl/AAD; Tut7Fl/Fl; 
Zp3Cre Tg+ (Tut4/7cAAD) mice, where only a single copy of the catalytic-dead TUT4AAD 
protein is expressed during oogenesis. While a single copy of TUT4 supported oogenesis, the 
expression of the catalytic-dead TUT4AAD protein phenocopied the conditional ablation of 
TUT4/7 (Fig. 2a-e and Extended Data Fig. 4c, d). In summary, the function of TUT4/7 and 
specifically their uridylation activity are intrinsically required during oocyte growth to 
complete meiosis I and generate functional MII oocytes.  
 
To understand if a defective maternal transcriptome underpinned the Tut4/7cKO phenotype, we 
analyzed gene expression in Tut4/7CTL and Tut4/7cKO GV oocytes, which represent the 
terminal stages of oocyte growth just prior to the onset of meiotic maturation and ovulation. 
The analysis of respective transcriptomes revealed the deregulation of many genes (Fig. 3a). 
The majority of deregulated genes were upregulated in the absence of TUT4/7 (Fig. 3a and 
Extended Data Fig. 5a, b), an expected outcome of removing a component of an RNA 
degrading pathway. The same deregulation of gene expression was observed in Tut4/7cAAD as 
in Tut4/7cKO GV oocytes (Extended Data Fig. 6a, b). Gene ontology analysis of the 
deregulated genes did not identify any germline-specific processes but rather revealed 
generic, mostly metabolic pathways (Extended Data Fig. 6c). We therefore sought to probe 
the relationship between the deregulated genes and oogenesis. To this end, we analyzed five 
growing oocyte transcriptomes: primordial, primary, secondary, early and late antral 
oocytes4. We applied the Markov clustering (MCL) algorithm19 to group genes in terms of 
expression patterns across oocyte growth (Extended Data Fig. 6d). We next addressed if we 
could detect enrichment or depletion of the TUT4/7-dependent upregulated genes in any of 
the gene expression patterns. We identified significant enrichment in clusters where genes are 
downregulated across oogenesis (Fig. 3b). Conversely, depletion of the gene set was 
observed in clusters where genes were upregulated or remained unchanged across 
development (Fig. 3b). Thus, TUT4/7 and specifically their uridylation activity are required 
to degrade transcripts during oocyte growth; in essence, they sculpt a functional maternal 
transcriptome.  
 
Next we sought to understand why a group of defined transcripts is dependent upon TUT4/7-
mediated uridylation during oocyte growth. To this end, we performed TAIL-seq on 
Tut4/7cKO GV oocytes and analyzed the 3ʹ-terminome of the TUT4/7-dependent upregulated 
genes and unchanged genes. Interestingly, upon deletion of TUT4/7, the fraction of the 
TUT4/7-dependent upregulated genes with short poly(A) tails dramatically increased (Fig. 
3c), indicating that the failure to degrade the transcripts resulted in their accumulation with 
short poly(A) tails. TUT4/7-deficiency had little impact on terminal mono-uridylation in 
transcripts with short poly(A) tails (Extended Data Figure 7a, b). The oligo-uridylation of the 
TUT4/7-dependent upregulated genes with short poly(A) tails was dependent upon TUT4/7 
with not a single oligo-uridylated read for TUT4/7-dependent upregulated genes observed in 
Tut4/7cKO GV oocyte libraries (Fig. 3d and Extended Data Fig. 7a). The ratio of oligo- to 
mono-uridylation of transcripts with short poly(A) tails, a defining feature of the GV oocyte 
transcriptome, was dependent upon TUT4/7 function (Fig. 3e). Thus, the loss of TUT4/7-
dependent oligo-uridylation in GV oocytes results in the accumulation of transcripts with 
short poly(A) tails. 
 
One can argue that the loss of a central RNA degradation targeting pathway will inevitably be 
detrimental to oogenesis or indeed any cell type or tissue. We therefore sought to understand 
if TUT4/7-mediated uridylation is a ubiquitous regulator of mRNA degradation. To this end, 
we combined the ubiquitously-expressed tamoxifen inducible Cre (R26ERTCre) allele with the 
Tut4Fl and Tut7Fl alleles to generate control Tut4+/Fl; Tut7+/Fl; R26ERTCre/+ and experimental 
Tut4Fl/Fl; Tut7Fl/Fl; R26ERTCre/+ mice. ESCs and MEFs were derived from these mice and 
tamoxifen treatment used to induce deletion, generating control Tut4+/-; Tut7+/-; R26ERTCre/+ 
(Tut4/7CTL) and experimental induced Tut4-/-; Tut7-/-; R26ERTCre/+ (Tut4/7iKO) cell lines 
(Extended Data Fig. 8). The loss of TUT4/7 did not impact ESC/MEF proliferation, ESC 
pluripotency or differentiation (Extended Data Fig. 8). We also administered tamoxifen in 
vivo to generate Tut4/7CTL and Tut4/7iKO adult mice; sampling of liver and bone marrow 
confirmed complete deletion in the respective tissues (Extended Data Fig. 7e), and these mice 
appeared healthy up to several months after deletion. We next performed TAIL-seq on the 
respective transcriptomes to gain insight into terminal mRNA uridylation in vivo. The loss of 
TUT4/7 did not grossly impact the poly(A) tail length profile of the transcriptomes in the 
respective cell types (Fig. 4a). However, both mono-uridylation and to a higher extent oligo-
uridylation were reduced in all the respective transcriptomes (Extended Data Fig. 7b-d). 
Furthermore, the reduction of uridylation in the respective transcriptomes did not 
significantly affect other terminal mRNA modifications (Extended Data Fig. 9). In contrast to 
oocytes, the miRNA pathway is functional in somatic cells20,21. TUT4/7-deficiency overall 
had a very modest impact on miRNA expression levels (Fig. 4b and Extended Data Fig. 10a). 
In ESCs, where LIN28a is expressed and TUT4/7-mediated oligo-uridylation inhibits pre-let-
7 processing18,22, an increase in let-7 dosage was observed in the absence of TUT4/7. The 
opposite effect was seen in liver, bone marrow and MEFs (Fig. 4b and Extended Data Fig. 
10a), where LIN28 is not expressed and TUT4/7-mediated mono-uridylation promotes 
specific pre-let7 processing23. The loss of TUT4/7 resulted in the reduction of terminal 
uridylation with a more severe reduction observed for let-7 family members in all somatic 
cells analyzed (Extended Data Fig. 10b). No significant impact on terminal miRNA 
adenylation, cytidylation or guanylation was observed in the respective Tut4/7iKO cells/tissues 
(Extended Data Fig. 10c-e). Finally, the loss of TUT4/7 with the consequent reduction of 
terminal mRNA uridylation and modest alterations to the miRNome did not have any 
appreciable impact on the gene expression within any of the cell types/tissues analyzed (Fig. 
4c and Extended Data Fig. 5c-f). In summary, TUT4/7-mediated uridylation is not an 
essential requirement for mRNA degradation in somatic cells. However, given that TUT4/7 
are broadly expressed, one cannot exclude a function for TUT4/7-mediated mRNA 3ʹ 
uridylation beyond steady state in managing somatic cell stress responses. 
 
A widely recognized feature in building a maternal transcriptome is the necessity to stabilize 
RNA that is achieved by stabilizing RNA binding proteins such as MSY224 and the 
downregulation of RNA degradation pathways25,26. However, limited degradation is also 
required to define the maternal transcriptome inferred by the distinct transcriptomes of 
growing oocyte stages4 and data presented herein. The consequence of failing to degrade 
transcripts during oocyte growth results in the overexpression of ~700 genes and generates a 
dysfunctional maternal transcriptome, poisoning oocyte maturation. A very short poly(A) tail 
likely provides the recognition signal to engage the TUT4/7-mediated 3ʹ uridylation pathway. 
Indeed, a poly(A) tail length of less than ~27 nucleotides leads to a loss of PABP 
occupancy12,13 and is a proven substrate for TUT4/7 binding and subsequent uridylation9. In 
addition, the failure to degrade the TUT4/7-dependent transcripts results in their 
accumulation with ~10 nucleotide poly(A) tails. The derailing of meiotic maturation in 
Tut4/7cKO mice may arise from alterations to the proteome and/or the accumulation of these 
transcripts with short poly(A) tails. Oligo-uridylation appears to be the primary signal that 
instructs transcript degradation in oocytes, as evidenced by the observation that TUT4/7-
deficiency modestly affects terminal mono-uridylation but abolishes oligo-uridylation in the 
TUT4/7-targeted transcripts with short poly(A) tails. A positive correlation between poly(A) 
tail length and translation efficiency of maternal transcripts is a conserved feature of early 
animal development27–30. Here we show a function for 3ʹ terminal uridylation and poly(A) tail 
length in the formation of the maternal mammalian transcriptome. Thus, poly(A) tail length 
regulation is important for both defining and activating the maternal transcriptome. 
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Figure 1 | The oocyte transcriptome is characterized by short poly(A) tails and oligo-
uridylation. a, Schematic representation of folliculogenesis and ovulation. b, Frequency of 
transcripts plotted against poly(A) tail length (8-78 nucleotides) in liver, bone marrow (BM), 
mouse embryonic fibroblasts (MEFs), embryonic stem cells (ESCs) and germinal vesicle 
(GV) oocyte transcriptomes. Data points and horizontal lines represent biological replicates’ 
mean and range, respectively. The number of transcripts / number of genes / percentage of 
transcripts with poly(A) tail length shorter than 79 nucleotides are 724,498 / 8,395 / 47% for 
liver, 52,809 / 5,292 / 9% for BM, 130,313 / 6,884 / 19% for MEFs, 123,459 / 7,681 / 20% 
for ESCs, and 1,035,640 / 11,747 / 35% for GV oocytes. c, Percentage of mRNA 3ʹ terminal 
transcriptome uridylation. The number of uridylated transcripts and in parentheses the 
number of genes represented by those transcripts are shown. d, Relative frequency of 
indicated U-tail length for transcripts with short (≤ 30 nucleotides) poly(A) tails. e, Ratio of 
oligo- to mono-uridylation for transcripts with short (≤ 30 nucleotides) poly(A) tails. The 
total numbers of oligo- and mono-uridylated transcripts and in parentheses the numbers of 
genes represented by those transcripts are shown. Data points represent biological replicates; 
the bars’ heights and vertical lines indicate the mean and range, respectively, for (c-e). 
 
Figure 2 | Infertility and defective oocyte maturation in Tut4/7cKO mice.  
a, Number of pups born per plug from Tut4/7CTL, Tut4/7cKO and Tut4/7cAAD mice. The number 
of animals tested, the mean and s.d. are indicated (t-test; ***, p < 0.001). b, Number of 
ovulated oocytes harvested after hormonal stimulation. Center values and error bars indicate 
the mean and s.d., respectively. The number of mice analyzed is n=8 for Tut4/7CTL, n=7 for 
Tut4/7cKO and n=6 for Tut4/7cAAD mice. c, Representative ovary sections stained with H&E 
for Tut4/7CTL, Tut4/7cKO and Tut4/7cAAD mice. Scale bars indicate 200 µm. d, In vitro 
development of oocytes isolated from Tut4/7CTL, Tut4/7cKO and Tut4/7cAAD mice that had been 
mated with wild type males of proven fertility. The fraction of oocytes with sperm contact or 
zygotes at the 2-pronuclei (2PN), 2-cell, 4-cell, 8-cell, morula and blastocyst stages is shown 
over five consecutive days. The number of mice and oocytes/embryos analyzed is: Tut4/7CTL, 
n=137 embryos, n=5 mice; Tut4/7cKO, n=119 embryos, n=6 mice and Tut4/7cAAD, n=15 
embryos, n=2 mice. e, Representative confocal immunofluorescence micrographs showing 
Tut4/7CTL (panel I) and abnormal Tut4/7cKO (panel II-IV) MII oocytes stained with anti-
tubulin antibody (green) and DNA stained with Hoechst 33342 (red, left). Scale bars indicate 
10 µm. The frequency of abnormal MII oocytes is presented for the respective genotypes 
(right). The number of oocytes and mice analyzed is: Tut4/7CTL, n=117 oocytes, n=3 mice; 
Tut4/7cKO, n=171 oocytes, n=5 mice and Tut4/7cAAD, n=77 oocytes, n=2 mice. 
 
Figure 3 | Short poly(A) tail length and TUT4/7-mediated oligo-uridylation target 
oocyte transcripts for degradation. a, Expression scatterplot showing relative average 
expression of transcripts between Tut4/7CTL and Tut4/7cKO germinal vesicle (GV) oocytes. 
Significantly deregulated (p < 0.01) genes with a fold change greater than 2 are highlighted in 
red. b, Enrichment and depletion analysis of Tut4/7cKO upregulated transcripts in gene 
expression clusters. The p-values for enrichment are indicated on the top blue bar and those 
for depletion on the bottom red bar. The hyper-geometric test was used to establish the 
significance. n represents the number of transcripts defining the cluster and x the number of 
Tut4/7cKO upregulated transcripts within the cluster. c, Frequency of transcripts plotted 
against poly(A) tail length (8-78 nucleotides) in Tut4/7CTL and Tut4/7cKO germinal vesicle 
(GV) oocyte. Transcripts upregulated and not upregulated in Tut4/7cKO oocytes are indicated 
in red and black, respectively. Data points and horizontal lines represent biological replicates’ 
mean and range, respectively. The number of transcripts / number of genes / percentage of 
transcripts with poly(A) tail length shorter than 79 nucleotides are 1,020,715 / 11,160 / 35% 
for Tut4/7CTL (not upregulated), 14,925 / 598 / 36% for Tut4/7CTL (upregulated), 173,641 / 
8,790 / 30 % for Tut4/7cKO (not upregulated), and 6,223 / 549 / 46% for Tut4/7cKO 
(upregulated). d, Quantification of mRNA 3ʹ oligo-uridylation of transcripts upregulated and 
not upregulated in Tut4/7cKO oocytes with short (≤ 30 nucleotides) poly(A) tails from 
Tut4/7CTL and Tut4/7cKO GV oocytes. The numbers of oligo-uridylated transcripts and in 
parentheses the number of genes represented by these transcripts are shown. The bars’ 
heights and vertical lines indicate the mean and range, respectively. e, Ratio of oligo- to 
mono-uridylation for transcripts with short (≤ 30 nucleotides) poly(A) tails from Tut4/7CTL 
and Tut4/7cKO GV oocytes. The fold change and the significance are indicated (one-tailed t-
test; *, p < 0.05) (c-e). The data for the Tut4/7CTL samples are derived from the libraries 
presented in Fig. 1. 
 
Figure 4 | TUT4/7-dependent RNA uridylation in different tissues and cell lines does not 
impact gene expression. 
a, Frequency of transcripts plotted against poly(A) tail length (8-78 nucleotides) from 
Tut4/7CTL and Tut4/7iKO liver, bone marrow (BM), mouse embryonic fibroblast (MEFs), 
embryonic stem cell (ESCs) transcriptomes. Data points and horizontal lines represent 
biological replicates’ mean and range, respectively. The data for the Tut4/7CTL samples are 
derived from the libraries presented in Fig. 1. For the Tut4/7iKO libraries the number of 
transcripts / number of genes / percentage of transcripts with poly(A) tail length shorter than 
79 nucleotides are 1,604,023 / 9,986 / 51% for liver, 62,284 / 5,638 / 8% for BM, 115,624 / 
6,754 / 27% for MEFs, and 113,808 / 6,897 / 25% for ESCs. b, miRNA expression 
scatterplots showing relative average miRNA expression levels between Tut4/7CTL and 
Tut4/7iKO tissues and cell lines. Let-7 family members and other miRNAs with significant (p 
< 0.05) and more than 2-fold change in expression levels are highlighted in red and blue, 
respectively. The linear regression fit is shown in red. c, Expression scatterplots showing 
relative average expression of transcripts between Tut4/7CTL and Tut4/7iKO tissues and cell 




Mice and alleles used in this study  
For the Tut4HA-GFP allele, we inserted the sequence encoding FLAG-HA2-PreScission-His6x-
eGFP (FHpHG) after the endogenous ATG initiation codon within exon 3, the first coding 
exon of Tut4. A targeting construct was recombineered that contained homology arms and a 
loxP flanked neomycin cassette 3′ of exon 3. Southern blotting of genomic NheI-digested 
DNA from individual ESC-derived clones with a 3′ probe was used to identify homologous 
recombinants. A 12.0-kb DNA fragment corresponds to the wild type Tut4 locus; integration 
of the loxP flanked neomycin cassette 3′ of exon 3 introduced an additional NheI site, thus 
decreasing the size of the NheI DNA fragment to 7.1 kb in the targeted allele. Cre-mediated 
recombination and excision of the loxP flanked neomycin cassette resulted in a 5.2-kb NheI 
DNA fragment recognized by the 3′ probe, which is diagnostic of the Tut4HA-GFP allele. 
For the Tut7HA-GFP allele, we inserted the sequence encoding FLAG-HA2-eGFP (FHG) after 
the endogenous ATG initiation codon within exon 2, the first coding exon of Tut7. A 
targeting construct was recombineered that contained homology arms and a loxP flanked 
neomycin cassette 3′ of exon 2. Southern blotting of genomic BamHI-digested DNA from 
individual ESC-derived clones with a 3′ probe was used to identify homologous 
recombinants. A 12.2-kb DNA fragment corresponds to the wild type Tut7 locus; integration 
of the loxP flanked neomycin cassette 3′ of exon 2 introduced an additional BamHI site, thus 
decreasing the size of the NheI DNA fragment to 6.2 kb in the targeted allele. Cre-mediated 
recombination and excision of the loxP flanked neomycin cassette resulted in a 4.3-kb 
BamHI DNA fragment recognized by the 3′ probe, which is diagnostic of the Tut7HA-GFP 
allele. 
For the Tut4Fl allele, we flanked exon 14 and 15 with loxP sites, Cre-mediated deletion of 
which results in out-of-frame splicing between exon 13 and 16, leading to a premature stop 
codon. To generate this allele, a targeting construct was generated that contains homology 
arms, an FRT flanked neomycin cassette and a loxP site 5′ of exon 14 and a second loxP site 
3’ of exon 15. Southern blotting of genomic BamHI-digested DNA from individual ESC-
derived clones with a 5′ probe was used to identify homologous recombinants. A 16.9-kb 
DNA fragment corresponds to the wild type Tut4 locus; integration of the FRT flanked 
neomycin cassette 3′ of exon 15 introduces an additional BamHI site, thus decreasing the size 
of the BamHI DNA fragment to 7.0 kb in the targeted allele. Flp-mediated recombination 
removed the FRT flanked neomycin cassette and generated the Tut4Fl allele that can be 
identified with the 3’ probe as a 13.1-kb EcoRV DNA fragment. Cre-mediated recombination 
and excision of exon 14 and 15 resulted in a 10.6-kb EcoRV DNA fragment recognized by 
the 3′ probe, which is diagnostic of the Tut4 null (Tut4-) allele. 
For the Tut7Fl allele, we flanked exon 15 with loxP sites, Cre-mediated deletion of which 
results in out-of-frame splicing between exon 14 and 16, leading to a premature stop codon. 
To generate this allele, a targeting construct was generated that contains homology arms, an 
FRT flanked neomycin cassette and a loxP site 5′ and 3’ of exon 15. Southern blotting of 
genomic EcoRV-digested DNA from individual ESC-derived clones with a 5′ probe was used 
to identify homologous recombinants. A 15.9-kb DNA fragment corresponds to the wild type 
Tut7 locus; integration of the FRT flanked neomycin cassette 5′ of exon 15 introduces an 
additional EcoRV site, thus decreasing the size of the EcoRV DNA fragment to 8.8 kb in the 
targeted allele. Flp-mediated recombination removed the FRT flanked neomycin cassette and 
generated the Tut7Fl allele that can be identified with the 3’ probe as a 6.9-kb EcoRV DNA 
fragment. Cre-mediated recombination and excision of exon 15 resulted in a 5.2-kb EcoRV 
DNA fragment recognized by the 3′ probe, which is diagnostic of the Tut7 null (Tut7-) allele. 
In order to generate the Tut4AAD allele we replaced wild type exon 15 with a mutant exon 
where the aspartic acid 1026 and 1028 codons are mutated to encode alanine. A targeting 
construct was recombineered that contains homology arms and a FRT flanked neomycin 
cassette 3′ of exon 15 that contains the D1026A and D1028A mutations. Southern blotting of 
genomic BamHI-digested DNA from individual ESC-derived clones with a 5′ probe was used 
to identify homologous recombinants. A 16.9-kb DNA fragment corresponds to the wild-type 
Tut4 locus; integration of the FRT flanked neomycin cassette 3′ of exon 15 introduces an 
additional BamHI as well as a PmeI site, thus decreasing the size of the BamHI DNA 
fragment to 12.4 kb in the targeted allele. Flp-mediated recombination and excision of the 
FRT flanked neomycin cassette removes the additional BamHI site and results in a 10.5-kb 
BamHI-PmeI DNA fragment recognized by the external 5′ probe, which is diagnostic of the 
Tut4AAD allele. 
The targeting for all alleles was performed in A9 ESCs. Southern blotting as described above 
of the individual ESC-clone-derived DNA was used to identify homologous recombinants. 
A9-targeted ESCs were injected into C57BL/6 eight-cell-stage embryos as described31. The 
targeted Tut4HA-GFP-Neo/+ and Tut7HA-GFP-Neo/+ mice were crossed to Deleter Cre mice32 to 
remove the loxP flanked neomycin cassette and generate Tut4HA-GFP/+ and Tut7HA-GFP/+ mice, 
respectively. The targeted Tut4Neo/+, Tut7Neo/+ and Tut4AAD-Neo/+ mice were crossed to FLP-
expressing transgenic mice33 to remove the FRT flanked neomycin cassette and generate 
Tut4Fl/+, Tut7Fl/+ and Tut4AAD/+ mice, respectively. Mice heterozygous for the Tut4Fl and 
Tut7Fl allele were further crossed to Deleter Cre mice32 to generate the Tut4- and Tut7- allele, 
respectively. The mice analyzed in this study were on a C57Bl/6 genetic background. The 
Zp3Cre allele16 and the R26ERTcre allele34 were also used in this study. To induce Cre-
mediated gene deletion, mice of two months of age were intraperitoneally injected with a 
dose of 75 mg tamoxifen/kg body weight for a total of five times. Tamoxifen was 
administered every other day, with a break of three weeks between the third and fourth 
injection. Mice were allowed to recover for at least another three weeks after the last 
tamoxifen injection prior to tissue collection. 
All of the mice were bred and maintained at the EMBL Mouse Biology Unit, Monterotondo, 
in accordance with current Italian legislation (Article 9, 27. Jan 1992, number 116) under 
license from the Italian Health Ministry. 
 
Southern blotting 
DNA was restriction-digested, separated on a 0.8% agarose gel and transferred to a Hybond-
XL membrane (Amersham) in alkaline solution (0.4 M NaOH, 1.5 M NaCl). The blot was 
neutralized in 2X SSC solution, UV-crosslinked at 150 mJ and then prehybridized for two 
hours in prehybridization solution (0.5 M Na2HPO4, 1 mM EDTA, 5% SDS, 3% BSA). A 
DNA probe was labeled with the Random Primers DNA Labeling System (Thermo Fisher 
Scientific) according to the manufacturer’s manual. The membrane was hybridized overnight, 




Cells or homogenized tissues were incubated in lysis buffer (50 mM Tris pH 8.0, 150 mM 
NaCl, 5 mM MgCl2, 15% glycerol, 1 mM DTT, 0.5% sodium deoxycholate, 0.5% Triton X-
100, protease inhibitors) for 10 minutes on ice. After centrifugation at 14,000 g for 10 
minutes at 4°C, the supernatant was recovered, the protein extract separated on a 4-12% Bis-
Tris protein gel (Invitrogen) and transferred overnight by wet transfer onto a nitrocellulose 
membrane (GE Healthcare). The membrane was blocked with 3% milk/0.1% Tween-20 in 
PBS, incubated in primary antibody in 3% milk/0.1% Tween-20 in PBS overnight, washed in 
0.1% Tween-20 in PBS, and incubated with appropriate horseradish peroxidase-coupled 
secondary antibody (Amersham) in 3% milk/0.1% Tween-20 in PBS for one hour. Proteins 
were detected using the ECL Western Blotting Detection Reagent (Amersham). The 
antibodies anti-TUT4 (Proteintech, 18980-1-AP), anti-AGO2 (O’Carroll lab), anti-HA 
(Covance, MMS-101P) and anti-α-tubulin (Sigma, T9026) were used at 1:1000, anti-TUT7 (a 




HA-GFP-TUT4 and HA-GFP-TUT7 fusion proteins were stained using the anti-HA 
(Covance, MMS-101P) antibody. Ovaries were collected and fixed in 4% formaldehyde 
overnight and embedded in paraffin. Sections of 6 µm thickness were stained as described 
previously35. Free oocytes were fixed in 2% paraformaldehyde for 10 minutes and washed 
twice with 10% Normal Donkey Serum (NDS) (Sigma Aldrich), 0.1% BSA in PBS. Oocytes 
were then blocked with 10% NDS, 0.1 M Glycine and 2% BSA in PBS, permeabilized with 
0.1% Triton X-100, 10% NDS, 0.1% BSA in PBS and washed again. The anti-β-tubulin 
(Sigma Aldrich, T4026) primary antibody and the Alexa Fluor Donkey (Invitrogen, A-21202) 
secondary antibody were used at 1:200 and 1:1000, respectively. DNA was stained with 
5 µg/ml of Hoechst 33342 for 10 minutes at room temperature. Cells were mounted on slides 
for confocal microscopy. Images were acquired with a Leica TCS SP5 confocal microscope 
and Photoshop was used for cropping and other modifications that were equally performed on 
control and experimental samples. 
 
Oocyte collection 
For the collection of GV oocytes, three weeks old females were stimulated with 10 U of 
pregnant mare’s serum gonadotropin (PMSG) and their ovaries were removed and placed in 
M2 medium. GV oocytes were released from the somatic cells via manual mechanical 
separation as described4. GV oocytes were then washed in M2 medium. For MII oocytes 
collection, three weeks old females were injected with 10 U of PMSG and 48 hours later with 
10 U of human chorionic gonadotropin (hCG). Oocytes were collected 14 hours later from 
the oviduct.  
 
RNA extraction, quantification and quality control 
Total RNA was extracted using QIAzol lysis reagent (Qiagen) according to manufacturer’s 
instructions. RNA concentration was measured with a Qubit fluorometer (Invitrogen) and 
quality was verified with a Bioanalyzer (Agilent Technologies). 
 
TAIL-seq  
TAIL-seq libraries were generated and analyzed as described11 with the following 
modifications. Instead of performing a HiSeq asymmetric 50-250 base pair paired-end run, a 
100 base pair HiSeq symmetric paired-end run was used. The starting material used for all 
cells and tissues (except for oocytes) was 5 µg of total RNA. Biological replicates are shown 
for each tissue/cell. Approximately 100-150 ng of GV oocyte total RNA was mixed with 
850-900 ng of C. elegans total RNA in order to have sufficient RNA for TAIL-seq library 
preparation. To account for artifacts associated with PCR amplification, barcoded 3’ adapters 
were used with unique molecule identifiers and only one read per ligation event was used in 
the final analysis. To equalize read depth, the somatic libraries were multiplexed with four 
libraries sequenced per lane of an Illumina HiSeq 2000, whereas each GV oocyte library was 
run on two lanes of the same sequencer. The original TAIL-seq pipeline11 was used to 
determine the poly(A) tail length and map the reads. C. elegans transcripts in GV oocyte 
libraries were removed during the alignment of the reads to the mouse genome. The TAIL-
seq learning algorithm was validated using the previously published spikes-ins11. The 
pipeline precisely determined the length of the spikes-ins (Extended Data Fig. 2a). A 
systematic decrease in the read recovery for the spikes-ins with longer poly(A) tails 
(Extended Data Fig. 2b) was observed. To account for differences in read recoveries, a linear 
model was fitted to the spike-ins (log2) read recovery using the spike-in’s known poly(A) 
lengths as predictors (Extended Data Fig. 2b). The model was then used to predict the relative 
recovery for each nucleotide in the 8 to 79 nucleotide range. For poly(A) length analyses the 
read recovery of transcripts with poly(A) lengths in the range from 8 to less than or equal to 
78 nucleotides was adjusted according to their predicted recovery. To estimate the adjusted 
fraction of transcripts with poly(A) tails less than or equal to 78, the transcripts with poly(A) 
tails outside this range were assigned a poly(A) length of 79 nucleotides. 
 
Early embryo development assay 
Adult females were stimulated with 10 U of PMSG. After 48 hours the females were injected 
with 10 U of hCG and set up with a stud C57Bl/6 male of proven fertility. Plugs were 
checked on the following morning and zygotes were collected in M2 media (Sigma Aldrich) 
from the oviduct of plugged females. Embryos were cultured under 5% CO2 supplemented 
atmosphere at 37°C in KSOMaa Evolve media (Zenith Biotech) and the progression was 




Oocyte in vitro maturation assay and NSN/SN analysis 
GV oocytes were cultured in KSOMaa Evolve medium (Zenith Biotec) at 37°C and 5% CO2 
and their maturation was examined after 2, 4, 12 and 24 hours. Progression though meiosis 
was monitored by the germinal vesicle breakdown (GVBD) followed by the extrusion of the 
first polar body (PB). Cells were taken at each time point and processed as previously 
described for the immunofluorescence staining using anti-β-tubulin (Sigma Aldrich, T4026) 
antibody and Hoechst 33342 to monitor meiotic progression. For NSN/SN oocyte 
determination fully grown GV oocytes were collected from ovaries 44-46 hours after PMSG 
injection, fixed in 4% paraformaldehyde for 15 minutes and washed three times with 0.1% 
Tween 20, 3% BSA in PBS. Oocytes were permeabilized in 0.5% Triton X-100, 3% BSA in 
PBS for 35 minutes and washed three times with 0.1% Tween 20, 3% BSA in PBS. Oocytes 
were then stained with Hoechst 33342 for 20 minutes and mounted on Teflon coated slides 
(Dutscher scientific). 
 
Gene expression analysis 
For microarray profiling of oocytes, biotinylated cDNA was synthesized from total RNA 
using the Ovation Pico WTA System V2 kit (NuGen). The fragmentation and labeling was 
done using the Encore Biotin Module (NuGen). For all other cells and tissues, biotinylated 
cDNA was synthesized from total RNA using the Ambion WT Expression kit. The 
fragmentation and labeling was done using the GeneChip WT Terminal Labeling and 
Controls kit (Affymetrix). Next, cDNA was hybridized for 16 hours at 45°C on a GeneChip 
Mouse Gene 2.0 ST Array (Affymetrix). GeneChips were washed and stained in the 
Affymetrix Fluidics Station 450. Biological replicates were used for the analyses; GV 
Tut4/7CTL, n=3; GV Tut4/7cKO, n=4; GV Tut4/7cAAD, n=3; Liver Tut4/7CTL, n=3; liver 
Tut4/7iKO, n=3; BM Tut4/7CTL, n=2; BM Tut4/7iKO, n=2; MEFs Tut4/7CTL, n=3; MEFs 
Tut4/7iKO, n=3; ESCs Tut4/7CTL, n=3; ESCs Tut4/7iKO, n=3). 
For qRT-PCR, total RNA was reverse-transcribed using SuperScript III and random 
hexamers (both Invitrogen) according to manufacturer’s instructions. qRT-PCR was 
performed using the LightCycler 480 SYBR Green I Master mix (Roche), and samples were 
run in technical duplicates or triplicates on a Roche LightCycler 480 instrument. Ct values 
were normalized against the internal controls Polr2a, Gapdh, or Sod1. Fold differences in 
expression levels were calculated according to the 2−ΔΔCT method36. 
 
Statistics 
For RNA profiling, robust multi-array average (RMA) was used to normalize the raw data 
and differential expression was determined with the limma package37. Adjusted p-values for 
the moderated t-statistic were used. For the cluster analysis of transcripts across 
folliculogenesis, we used the previously described dataset4. Transcripts were clustered using 
the Markov clustering (MCL) algorithm implemented in the BioLayout express software19. 
The MCL inflation value was set at 2.2. The enrichment or depletion of upregulated genes in 
each cluster was determined using the hypergeometric test. Gene ontology enrichment was 
established with Fisher’s exact test using the R topGO package. T-tests were used to compare 
differences between treatments assuming equal variance and, unless otherwise stated, were 
two-tailed. All comparisons were made only using biological replicates as data points. 
Pearson’s chi-squared test was used to determine the differences in the levels of mono and 
oligo-uridylation between upregulated and not upregulated genes in TUT4/7 deficient 
oocytes and control oocytes. Fisher's exact tests were used to evaluate the differences 
between oocytes in SN and NSN and follicles with developed and underdeveloped antra for 
Tut4/7CTL and Tut4/7cKO animals. 
Data reporting 
No statistical methods were used to predetermine sample size. The experiments were not 




Ovaries from adult females were collected and fixed in Bouins solution overnight and 
embedded in paraffin. Standard Periodic Acid-Schiff (PAS) staining was performed on 
sections 7 µm thick. 
 
MEF culture 
Primary MEFs were derived from embryonic day 13.5 embryos according to standard 
protocols. Cells were cultured in MEF medium (DMEM supplemented with 12.5% fetal calf 
serum, 2 mM L-glutamine, 1X non-essential amino acids, 100 units/ml 
penicillin/streptomycin and 100 µM β-mercaptoethanol (all Gibco)) at 37°C and 7.5% CO2. 
Immortalized MEFs were generated by two consecutive retroviral infections of passage 2 
primary MEFs with pBabeSV40LT (a gift from G. Hannon, Cold Spring Harbor Laboratory). 
To induce Cre-mediated gene deletion, cells were incubated with 600 nM 4-OH-tamoxifen in 
MEF medium for three days. To determine the growth curve for each line, 68,000 cells per 
well were plated in a 6-well plate in triplicate for each day of the experiment. Cells were 
trypsinized and counted with a Cellometer X2 Image Cytometer (Nexcelom). Cells were 
routinely tested for mycoplasma contamination by PCR; no further verification of the cell 
line identity was performed. 
 
 
ESC culture and differentiation 
ESCs were derived from mice backcrossed one generation into the 129S2/SvPasCrl (Charles 
River Laboratories) background as described38. Cells were maintained on 0.1% gelatin in 
ESC medium (KnockOut DMEM supplemented with 12.5% fetal calf serum, 2 mM L-
glutamine, 1X non-essential amino acids, 100 units/ml penicillin/streptomycin, 100 µM β-
mercaptoethanol (all Gibco), 1 µM PD0325901, 3 µM CHIR99021 (both University of 
Dundee), and 20 ng/ml LIF (EMBL Heidelberg)) at 37°C and 7.5% CO2. To induce Cre-
mediated gene deletion, cells were incubated with 400 nM 4-OH-tamoxifen in ESC medium 
for four days. To determine the growth curve for each line, 100,000 cells per well were plated 
in a 6-well plate in triplicate for each day of the experiment. Cells were trypsinized and 
counted with a Cellometer X2 Image Cytometer (Nexcelom). Cells were routinely tested for 
mycoplasma contamination by PCR; no further verification of the cell line identity was 
performed. 
For the alkaline phosphatase staining, ESCs were seeded at 3,000 cells in a 10-cm dish and 
cultured for eight days. Cells were then washed with PBS, air-dried and stained with AP 
staining solution (100 mM Tris pH 9, 100 mM NaCl, 5 mM MgCl2, 0.4 µg/ml naphtol 
phosphate and 1 µg/ml Fast Violet B (both Sigma)) for 15 minutes. Cells were washed again 
with PBS, air dried and analyzed. 
Embryoid bodies (EBs) were derived by culturing ESCs according to the hanging drop 
method39. Drops of EB differentiation medium (DMEM supplemented with 20% FCS, 2 mM 
L-glutamine, 1X non-essential amino acids, 100 units/ml penicillin/streptomycin and 100 µM 
β-mercaptoethanol (all Gibco)) containing 1,000 ES cells were placed onto the lids of culture 
dishes and cultured for two days. EBs were then transferred onto bacterial plates and cultured 
in suspension for another two days. For the cardiac differentiation assay, single EBs were 
plated onto gelatin-coated 24-well plates and checked daily for contractile activity. 
In vitro differentiation into neural progenitor cells was achieved by culturing ESCs on 0.1% 
gelatin in neuronal differentiation medium (1:1 mixture of DMEM/F-12 and Neurobasal-A 
medium supplemented with 0.5X N-2, 0.5X B-27 (all Gibco), 25 µg/ml BSA, 1 mM L-
glutamine, 10 µg/ml insulin, 150 nM thioglycerol, 1 µg/ml heparin (all Sigma) and 250 ng/ml 
FGF-basic (Peprotech)) for three days. 
 
Small RNA sequencing 
Small RNA libraries were generated using the NEBNext Multiplex Small RNA Library Prep 
Set for Illumina (Set 1) (NEB) according to manufacturer’s instructions. Samples from the 
same tissue or cell line were multiplexed, pooled and run in one lane of HiSeq. For the 
analysis of the small RNA-seq data, plain miRNA counts were identified from the small 
RNA-seq input samples, cleaned from their 3’ adapters and mapped against all mouse hairpin 
precursors of the miRBase, allowing up to two mismatches using Chimira40,41. Counts of 
multi-mapped reads were assigned only to the first optimal alignment call returned by 
BLASTn. Modification analysis was then restricted to pure modification events, i.e. mono-
[nt] or poly-[nt] patterns, where [nt] can be the nucleotides U, A, C or G. Poly-[nt] 
modifications refer to sequences of two or more identical nucleotides. Counts from all other 
miRNA variants were collapsed with their respective unmodified miRNA counts. 
Normalization of control and experimental samples and identification of differentially 
expressed miRNAs was done using the DESeq2 software package42. 
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Data Availability Statement 
All mRNA and miRNA expression data that support the findings of this study have been 
deposited at ArrayExpress under the accession number E-MTAB-5056 and E-MTAB-5677, 
respectively. The primary data and output of the TAIL-seq pipeline can be retrieved from 
http://www.ebi.ac.uk/research/enright/morgan-et-al-2017. The scripts used in the analysis of 
the TAIL-seq output can be found at https://github.com/marcosmorgan/TAIL-seq. The Tut4 
and Tut7 alleles will be freely available on a non-collaborative basis. All the other data 
generated or analysed during this study are included in the article and Supplementary 
Information. 
 
Extended Data Figure Legends 
 
Extended Data Figure 1 | Generation and analysis of Tut4 and Tut7 reporter alleles. a, 
Tut4HA-GFP reporter allele targeting strategy. Depicted at the top is the domain organization of 
the TUT4 protein consisting of C2H2 and CCHC-type zinc finger domains, an inactive 
nucleotidyl-transferase (iNT) domain, a polymerase-associated domain (PAD) and a 
nucleotidyl-transferase (NT) domain. Below it, the 5’ portion of the Tut4 locus, the targeting 
vector for the insertion of FLAG-HA2-PreScission-His6x-eGFP (FHpHG) into the first 
coding exon of Tut4 as well as the targeted Tut4 locus before and after Cre-mediated deletion 
of the loxP site (indicated by red triangles) flanked neomycin (neo) resistance cassette are 
shown. The position of the diphtheria toxin A (DTA) selection marker within the targeting 
vector is shown. The NheI restriction sites as well as the expected Southern fragments 
detected by the 3’ probe are indicated. Depicted at the bottom is the structure of the resulting 
HA-GFP-TUT4 protein. b, Tut7HA-GFP reporter allele targeting strategy for the insertion of 
FLAG-HA2-eGFP (FHG) into the first coding exon of Tut7 is depicted as in (a). The BamHI 
restriction sites as well as the expected Southern fragments detected by the 3’ probe are 
indicated. c, Southern blot of NheI-digested genomic DNA from wild type, Tut4HA-GFP-Neo/+ 
and Tut4HA-GFP/+ tails hybridized with the 3’ probe shown in (a). d, Southern blot of BamHI-
digested genomic DNA from wild type, Tut7HA-GFP-Neo/+ and Tut7HA-GFP/+ tails hybridized 
with the 3’ probe shown in (b). e, Western blot using anti-HA, anti-TUT4 and anti-tubulin 
antibodies on testis whole cell extracts of wild type, Tut4-/- and Tut4HA-GFP/HA-GFP mice is 
shown. f, Western blot using anti-HA, anti-TUT7 and anti-tubulin antibodies on testis whole 
cell extracts of wild type, Tut7-/- and Tut7HA-GFP/HA-GFP mice is shown. g, Confocal 
immunofluorescence micrographs of wild type, Tut4HA-GFP/HA-GFP and Tut7HA-GFP/HA-GFP ovary 
sections stained with anti-HA antibody (green) and Hoechst 33342 (blue) are shown as 
indicated. Broken white circles highlight the oocyte within the follicle. Insets are 
magnifications of the oocytes. Scale bars are 30 µm. 
 
Extended Data Figure 2 | Analysis of DNA spike-in standards used for TAIL-seq library 
preparations and mRNA uridylation counts. a, Cumulative frequency of poly(A) length 
determined by the TAIL-seq algorithm for the different standards used. b, Relative read 
recoveries of the spike-ins according to their poly(A) tail length. All standards were 
normalized to the spike-in of 0 length. The linear regression line is shown in blue. a indicates 
slope and b the y-intercept. c, Mono- and oligo-uridylation counts for transcript with short 
poly(A) tail length (≤ 30 nucleotides). The number of transcripts with short poly(A) tail 
length and the number of genes represented by these transcripts are shown for the indicated 
tissues and cell lines. 
 
Extended Data Figure 3 | Generation of conditional, null and catalytically inactive 
alleles for Tut4 and Tut7. a, Tut4 targeting and deletion strategy. Domain organization of 
TUT4/7 is presented as in Extended Data Fig. 1a. A portion of the Tut4 locus, the targeting 
vector used to introduce the loxP sites into the Tut4 locus to flank the exons 14 and 15 and 
the targeted Tut4 gene before and after Flp-mediated recombination as well as after Cre-
mediated recombination are shown. Green and red triangles represent FRT and loxP sites, 
respectively. Rectangles indicate the position of the neomycin (neo) and diphtheria toxin A 
(DTA) selection marker genes. The EcoRV and BamHI restriction sites as well as the 
expected Southern fragments detected by the 5’ probe are indicated. b, Tut7 targeting and 
deletion strategy. A portion of the Tut7 locus, the targeting vector used to introduce the loxP 
sites into the Tut7 locus to flank exon 15 and the targeted Tut7 gene before and after Flp-
mediated recombination as well as after Cre-mediated recombination are shown. The EcoRV 
restriction sites as well as the expected Southern fragments detected by the 5’ probe are 
indicated. c, Southern blot of BamHI digested genomic DNA from wild type and Tut4Neo/+ 
tails hybridized with the 5’ probe shown in (a). d, Southern blot of EcoRV-digested genomic 
DNA from wild type, Tut7Flox/Flox and Tut7-/- tails hybridized with the 5’ probe shown in (b). 
e, Western blot using anti-TUT4, anti-TUT7 and anti-tubulin antibodies on testis (Tes) and 
thymus (Thy) whole cell extracts of wild type, Tut4-/- and Tut7-/- mice. f, Targeting strategy 
used to generate the Tut4AAD allele. A portion of the Tut4 locus, the targeting vector used for 
the introduction of the D1026A and D1028A mutations and the targeted Tut4 gene before and 
after Flp-mediated recombination are shown. The BamHI and PmeI restriction sites as well as 
the expected Southern fragments detected by the 5’ probe are indicated. g, Chromatograms 
showing a portion of Tut4 exon 15 highlighting the two aspartate and alanine codons of wild 
type and Tut4AAD/AAD mice, respectively. h, Southern blot of BamHI-PmeI-digested genomic 
DNA from wild type and Tut4AAD/+ tails hybridized with the 5’ probe shown in (f). i, Western 
blots using anti-TUT4 and anti-AGO2 antibodies on testis whole cell extracts from wild type 
and Tut4AAD/AAD mice. 
 
Extended Data Figure 4 | Antral follicle morphology and in vitro oocyte maturation 
upon TUT4/7-deficiency. a, The frequency of developing and developed antral follicles in 
Tut4/7CTL and Tut4/7cKO mice is shown (Fisher’s exact test; N.S., not significant). The 
number of follicles and mice analyzed is: Tut4/7CTL, n=52 follicles, n=5 mice and Tut4/7cKO, 
n=49 follicles, n=5 mice. b, Representative confocal immunofluorescence micrographs of 
Tut4/7CTL and Tut4/7cKO fully grown germinal vesicle (GV) oocytes stained with Hoechst 
33342 are shown in the left panel. The non-surrounded nucleolus (NSN) and surrounded 
nucleolus (SN) states are indicated. Broken white circles highlight the oocytes. Scale bars 
indicate 20 µm. The frequency of NSN and SN state in Tut4/7CTL and Tut4/7cKO GV oocytes 
is shown in the right panel (Fisher’s exact test; *, p < 0.05) The number of oocytes and mice 
analyzed is: Tut4/7CTL, n=85 oocytes, n=3 mice and Tut4/7cKO, n=135 oocytes, n=3 mice. c, 
In vitro oocyte maturation of Tut4/7CTL, Tut4/7cKO and Tut4/7cAAD oocytes. The frequency of 
germinal vesicle (GV) oocytes, germinal vesicle breakdown (GVBD) oocytes and oocytes 
with polar bodies (PB) is shown at different time points after collection and culture. The 
number (n) of oocytes analyzed is: Tut4/7CTL n=160 oocytes, n=4 mice; Tut4/7cKO n=194 
oocytes, n=3 mice and Tut4/7cAAD n=183 oocytes, n=3 mice. d, Representative confocal 
immunofluorescence micrographs of in vitro maturating Tut4/7CTL, Tut4/7cKO and Tut4/7cAAD 
oocytes stained with anti-tubulin antibody (green) and DNA stained with Hoechst 33342 
(red) and the indicated time points are presented. Scale bars indicate 20 µm. 
 
Extended Data Figure 5 | Validation of gene expression changes upon loss of TUT4/7 in 
different tissues and cell lines. a-f, Relative expression of genes in Tut4/7CTL and Tut4/7cKO 
germinal vesicle (GV) oocytes (a, b) as well as Tut4/7CTL and Tut4/7iKO liver (c), bone 
marrow (BM, d), mouse embryonic fibroblasts (MEFs, e) and embryonic stem cells (ESCs, f) 
as determined by qRT-PCR is shown. Depicted are representative genes that have been 
determined to be upregulated (a) and unchanged (b-f) according to microarray profiling. Ct 
values were normalized against Polr2a, Gapdh, and Sod1. Data points represent biological 
replicates (n=3); the bars’ heights and vertical lines indicate the mean and the range, 
respectively. The fold change and significance are indicated (one-tailed t-test; *, p < 0.05; **, 
p < 0.01; ***, p < 0.001). 
 
Extended Data Figure 6 | RNA profiling analysis of Tut4/7cKO and Tut4/7cAAD germinal 
vesicle oocytes. a, b, Expression scatterplot showing relative average expression of 
transcripts between Tut4/7CTL and Tut4/7cAAD (a) as well as Tut4/7cKO and Tut4/7cAAD (b) 
germinal vesicle (GV) oocytes. Significantly deregulated (p < 0.01) genes with a fold change 
greater than 2 are shown in red. c, Gene ontology analysis for upregulated genes in Tut4/7cKO 
and Tut4/7cAAD GV oocytes; the top ten most significant pathways identified are shown. d, 
Diagram of oocyte growth stages that have been analyzed (left). The top 30 clusters resulting 
from the clustering analysis according to gene expression patterns across oocyte growth 
stages (x-axis) are shown (right). The average expression change for genes within the cluster 
is indicated by a black line with the standard deviation range indicated in gray.  
 
Extended Data Figure 7 | Loss of TUT4/7 reduces both mono- and oligo-uridylation in 
different tissues and cell lines. a, Transcript count for upregulated and not upregulated 
genes in Tut4/7CTL and Tut4/7cKO GV oocytes. The number of transcripts and in brackets the 
number of genes represented by those transcripts is presented. The p-value determined using 
the Pearson's chi-squared test is shown. b-d, Quantification of mRNA 3ʹ terminal mono- (b), 
oligo- (c) and total uridylation (d) of all transcripts (left panel) as well as those with short (≤ 
30 nucleotides) (center panel) and long (> 30 nucleotides) (right panel) poly(A) tails of 
Tut4/7CTL and Tut4/7cKO germinal vesicle (GV) oocytes as well as Tut4/7CTL and Tut4/7iKO 
liver, bone marrow (BM), mouse embryonic fibroblasts (MEFs) and embryonic stem cells 
(ESCs). Data points represent replicates; the bars’ heights and vertical lines indicate the mean 
and range, respectively. The fold reduction in uridylation and the significance are indicated 
(t-test; *, p < 0.05; **, p < 0.01; ***, p < 0.001). e, Southern blots of EcoRV-digested 
genomic DNA from Tut4/7CTL and Tut4/7iKO liver and bone marrow (BM) confirming 
deletion of Tut4 and Tut7 after tamoxifen administration. The expected sizes for the wild type 
(WT), the conditional (flox) and the null alleles are indicated. 
 
Extended Data Figure 8 | Deletion of Tut4/7 in mouse embryonic fibroblasts and stem 
cells. a, Strategy and timing for the acute deletion of Tut4/7 in mouse embryonic fibroblasts 
(MEFs). TMX denotes 4-OH-tamoxifen. b, Southern blots of EcoRV-digested genomic DNA 
from Tut4/7CTL and Tut4/7iKO MEF cell lines confirming deletion of Tut4 and Tut7. The 
expected sizes for the wild type (WT), the conditional (flox) and the null alleles are indicated. 
c, Western blots probed with the indicated antibodies from Tut4/7CTL and Tut4/7iKO MEF 
whole cell extracts. d, Growth curve of two independent Tut4/7CTL and Tut4/7iKO MEF cell 
lines. The mean and s.d. of three technical replicates is shown. e, Strategy and timing for the 
acute deletion of Tut4/7 in mouse embryonic stem cells (ESCs). f, Southern blots of EcoRV-
digested genomic DNA from Tut4+/Fl; Tut7+/Fl; R26ERTCre/+ and Tut4Fl/Fl; Tut7Fl/Fl; R26ERTCre/+ 
ESC lines before (TMX-) and after (TMX+) deletion of Tut4/7. The expected sizes for the 
wild type (WT), the conditional (flox) and the null alleles are indicated. g, Western blots 
probed with the indicated antibodies from Tut4/7CTL and Tut4/7iKO ESC whole cell extracts. 
h, Representative images showing morphology of Tut4+/Fl; Tut7+/Fl; R26ERTCre/+ and Tut4Fl/Fl; 
Tut7Fl/Fl; R26ERTCre/+ ESC lines before (TMX-) and after (TMX+) deletion of Tut4/7. Scale 
bar indicates 200 µm. i, Growth curve of Tut4+/Fl; Tut7+/Fl; R26ERTCre/+ and Tut4Fl/Fl; Tut7Fl/Fl; 
R26ERTCre/+ESC lines before (TMX-) and after (TMX+) deletion of Tut4/7. The growth of 
each line was measured in triplicates. The mean and s.d. of three independently-derived cell 
lines is shown. j, Alkaline phosphatase staining of untreated (TMX-) and tamoxifen treated 
(TMX+) Tut4+/Fl; Tut7+/Fl; R26ERTCre/+ and Tut4Fl/Fl; Tut7Fl/Fl; R26ERTCre/+ ESC lines. k, 
Relative expression of pluripotency markers in Tut4/7CTL and Tut4/7iKO ESC lines as 
determined by qRT-PCR from three biological replicates. The bars’ heights and vertical lines 
indicate the mean and range, respectively. The fold change is indicated. l, Representative 
images showing morphology of Tut4/7CTL and Tut4/7iKO embryoid bodies. m, Representative 
images showing morphology of neural progenitors derived from of Tut4/7CTL and Tut4/7iKO 
ESCs. Scale bar indicates 100 µm. n, Relative expression as determined by qRT-PCR of 
endoderm and mesoderm markers in embryoid bodies derived from Tut4/7CTL and Tut4/7iKO 
ESCs. The mean from three biological replicates is shown. The bars’ heights and vertical 
lines indicate the mean and range, respectively. The fold change is indicated. o, Expression as 
determined by qRT-PCR presented as fold change of pluripotency and neural progenitor 
markers upon differentiation of Tut4/7CTL and Tut4/7iKO ECSs into neural progenitors. The 
fold change is indicated. The bars’ heights and vertical lines indicate the mean and range, 
respectively (t-test; *, p < 0.05). p, Frequency of Tut4/7CTL and Tut4/7iKO embryoid bodies 
with spontaneous contractile activity. The mean from three biological replicates is shown, 
each determined from 48 embryoid bodies. The fold change is indicated. The bars’ heights 
and vertical lines indicate the mean and range, respectively. 
 
Extended Data Figure 9 | 3ʹ  mRNA terminal transcriptome cytidylation and 
guanylation are not affected upon Tut4/7 deletion. a, b, Quantification of mRNA 3ʹ 
terminal cytidylation (a) and guanylation (b) of all transcripts (left panel), transcripts with 
short poly(A) tails (≤ 30 nucleotides) (center panel) and long poly(A) tails (> 30 nucleotides) 
(right panel) from Tut4/7CTL and Tut4/7cKO or Tut4/7iKO germinal vesicle (GV) oocytes, liver, 
bone marrow (BM), mouse embryonic fibroblast (MEFs) and embryonic stem cell (ESCs) 
transcriptomes. The fold change in modification levels and the significance are indicated (t-
test; *, p < 0.05). Data points represent replicates; the bars’ heights and vertical lines indicate 
the mean and range, respectively. 
 
Extended Data Figure 10 | Loss of TUT4/7 specifically reduces terminal miRNA 
uridylation levels and modestly impacts miRNA expression levels. a, Quantification of the 
relative abundance of let-7 family members, the five most abundant miRNAs, and all other 
miRNAs in Tut4/7CTL and Tut4/7iKO liver, bone marrow (BM), mouse embryonic fibroblasts 
(MEFs) and embryonic stem cells (ESCs). The fold change in relative let-7 expression is 
depicted. b-e, Quantification of 3’ uridylation (b), adenylation (c), cytidylation (d), and 
guanylation (e) frequency of all miRNAs and let-7 family members in Tut4/7CTL and 
Tut4/7iKO cell lines and tissues. Modifications involving one or more than one nucleotide are 
distinguished. Data points represent replicates; the bars’ heights and vertical lines indicate the 
mean and range, respectively. The fold change in modification frequency between Tut4/7CTL 
and Tut4/7iKO as well as the significance are indicated (t-test; *, p < 0.05; **, p < 0.01; ***, p 
< 0.001). 
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GO ID GO term p value
GO:0010556 regulation of macromolecule biosynthetic process 4.2e−13
GO:0010468 regulation of gene expression 5.2e−13
GO:2000112 regulation of cellular macromolecule biosynthetic process 6.5e−13
GO:0051252 regulation of RNA metabolic process 1.5e−12
GO:0051171 regulation of nitrogen compound metabolic process 1.7e−12
GO:0031326 regulation of cellular biosynthetic process 2.3e−12
GO:0006355 regulation of transcription, DNA-templated 2.4e−12
GO:1903506 regulation of nucleic acid-templated transcription 2.4e−12
GO:2001141 regulation of RNA biosynthetic process 2.6e−12
GO:0009889 regulation of biosynthetic process 2.8e−12
























































































































































































































































































































































































































































































































































































































































































































































Mono-U Oligo-U Total 
Short tails Upregulated Tut4/7CTL 14 (7) 24 (13) 2916 (450) 
Tut4/7cKO 9 (4) 0 (0) 2725 (375) 
p = 0.50 p = 5.59e-6 
Not upregulated Tut4/7CTL 604 (338) 447 (201) 162824 (8603) 
Tut4/7cKO 203 (82) 34 (19) 30460 (4800) 
p = 3.04e-13 p = 2.28e-7 
Long tails Upregulated Tut4/7CTL 115 (48) 5 (3) 30767 (611) 
Tut4/7cKO 26 (15) 5 (2) 7911 (572) 
p = 0.62 p = 0.05 
Not upregulated Tut4/7CTL 5242 (1850) 196 (120) 2227670 (11719) 
Tut4/7cKO 1117 (628) 78 (57) 422525 (9947) 
p = 4.29e-4 p = 2.39e-8 
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Gel source data - western blots
